Amarnani, R., Travis, S., & Javaid, M. (2020). Novel use of burosumab in refractory iron-induced FGF23-mediated hypophosphataemic osteomalacia. Oxford University Press.
Citace podle Chicago (17th ed.)Amarnani, R., S. Travis, a MK Javaid. Novel Use of Burosumab in Refractory Iron-induced FGF23-mediated Hypophosphataemic Osteomalacia. Oxford University Press, 2020.
Citace podle MLA (9th ed.)Amarnani, R., et al. Novel Use of Burosumab in Refractory Iron-induced FGF23-mediated Hypophosphataemic Osteomalacia. Oxford University Press, 2020.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..